Project Grant R21DA062273
Award Date
9/30/24
Completion Date
9/29/26
Dollars Obligated
$432K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07107, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a $994,004 research study titled "The Youth Empowerment Study (YES)" to explore perceptions of overdose risk, the unregulated drug supply, and safety precautions among adolescents (ages 13-17) and young adults (ages 18-25). The study aims to investigate perspectives of families, youth providers, pharmacists, and people who use...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will develop and evaluate the efficacy of a universal overdose prevention intervention to be delivered in primary care settings. The $2,467,574 award, effective September 30, 2024, aims to increase youth awareness of fentanyl and other emerging drug risks, knowledge of overdose risk reduction strategies, and ability to recognize and respond to overdoses....
The National Institute on Drug Abuse (NIDA) awarded a $193,336 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Trustees of Dartmouth College to evaluate a pharmacist-integrated model of opioid use disorder (OUD) treatment in primary care settings. The goal is to investigate if this model can increase the co-prescribing of naloxone, the opioid overdose antidote, to patients receiving medication treatment for OUD. The research project aims to: 1) describe federal,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $218,900.00 to Rutgers, The State University of New Jersey, to characterize the formation and maintenance of drug-biased beliefs in individuals with opioid use disorder (OUD). The key objectives of this research project are to: 1) quantify domain-specific optimism biases in OUD and assess their longitudinal maintenance, 2) investigate the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,717,104 over 3 years to adapt and pilot test a Youth Overdose Prevention Toolkit for use in pediatric healthcare settings. The project aims to develop practical, developmentally-appropriate guidance for delivering evidence-based overdose prevention interventions such as naloxone, take-home drug testing, harm reduction education, and...
This federal Project Grant award of $3,503,736 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county legal systems. The key products and services to be delivered under this 2-year R61 phase and 3-year R33 phase award include: 1) co-designing a multilevel SUD/overdose prevention strategy with...
This $2,316,128 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to design and assess tailored harm reduction strategies to address the heterogeneous overdose epidemic across six distinct jurisdictions. The project, titled "Reversing Overdose Epidemics through Simulation, Collaboration, and Unified Efforts (RESCUE)", will collaborate with health departments and community partners to evaluate the...
The National Institute on Drug Abuse (NIDA) awarded a $882,816 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Rutgers, The State University in New Jersey. The 4-year grant, running from June 1, 2025 to February 28, 2029, will fund research to evaluate the comparative effectiveness of behavioral, pharmacological, and combination treatments for patients with co-occurring post-traumatic stress disorder (PTSD) and substance use disorder (SUD). The research will use...
This federal Project Grant award for $1,499,606 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to characterize health outcomes and disparities in children born to individuals with opioid use disorder (OUD). The key products and services to be delivered through this 5-year grant include: Examining variation in the diagnosis of neonatal opioid withdrawal syndrome (NOWS) across 150 hospitals and identifying...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to optimize an online behavioral intervention to prevent and reduce substance use among high school seniors, a critical transition period. The $1,702,558 award will fund the development and evaluation of an innovative, technology-driven intervention targeting social influences linked to substance use. The project will employ human-centered...